Indian Journal of Gastroenterology

, Volume 38, Issue 1, pp 55–60 | Cite as

Legume intake and risk of nonalcoholic fatty liver disease

  • Alireza Bahrami
  • Farshad Teymoori
  • Tannaz Eslamparast
  • Golbon Sohrab
  • Ehsan Hejazi
  • Hossein Poustchi
  • Azita HekmatdoostEmail author
Original Article



It is known that diet plays a pivotal role in the pathogenesis and management of nonalcoholic fatty liver disease (NAFLD); however, the knowledge on the role of different food groups such as legumes is not enough.


We designed this study to assess the relationship between legume intake and risk of NAFLD in framework of a case-control study among Tehrani adults. One hundred and ninety-six newly diagnosed patients with NAFLD and 803 controls were studied, and their dietary intake was assessed using a valid and reliable food frequency questionnaire. Conditional logistic regression was used to determine the odds ratio (OR) of NAFLD per increase of one serving/week dietary legumes, lentil, and beans adjusting for potential confounders.


In energy-adjusted model, greater intake of legumes, lentils, and beans was associated with a lower risk of NAFLD. These risk associations remained significant after adjusting for all known risk factors of NAFLD. OR of NAFLD in adjusted models for higher dietary intake of legumes, lentils, and beans were 0.73 (0.64–0.84), 0.61 (0.46–0.78), and 0.35 (0.17–0.74), respectively.


Our findings suggest that higher intake of total legumes (beans, lentils, and peas) was associated with lower risk of NAFLD.


Bean Legumes Lentil Nonalcoholic fatty liver disease 



This study is related to the project NO. 1396/114499 From Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding information

The “Student Research Committee” and “Research and Technology Chancellor” in Shahid Beheshti University of Medical Sciences financially supported this study.

Compliance with ethical standards

Conflict of interest

AB, FT, TE, GS, EH, HP, and AH declare that they have no conflict of interest.

Ethics statement

The authors declare that the study was performed in a manner conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer. com. The study was approved by the ethics committee of National Nutrition and Food Technology Research Institute, Tehran, Iran.


The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, or the printer/publishers are responsible for the results/findings and content of this article.


  1. 1.
    Mokhtari Z, Gibson DL, Hekmatdoost A. Nonalcoholic fatty liver disease, the gut microbiome, and diet. Adv Nutr. 2017;8:240–52.CrossRefGoogle Scholar
  2. 2.
    Duseja A, Singh SP, Saraswat VA et al. Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015;5:51–68.Google Scholar
  3. 3.
    Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664–9.CrossRefGoogle Scholar
  4. 4.
    Kanuri G, Bergheim I. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). Int J Mol Sci. 2013;14:11963–80.CrossRefGoogle Scholar
  5. 5.
    Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28:339-50.Google Scholar
  6. 6.
    Farrell GC, Wong VW, Chitturi S. NAFLD in Asia—as common and important as in the west. Nat Rev Gastroenterol Hepatol. 2013;10:307–18.CrossRefGoogle Scholar
  7. 7.
    Moghaddasifar I, Lankarani K, Moosazadeh M, et al. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int J Organ Transplant Med. 2016;7:149–60.Google Scholar
  8. 8.
    Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42:44–52.CrossRefGoogle Scholar
  9. 9.
    Valenti L, Dongiovanni P, Piperno A, et al. α1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Hepatology. 2006;44:857–64.Google Scholar
  10. 10.
    Ghaemi A, Taleban FA, Hekmatdoost A, et al. How much weight loss is effective on nonalcoholic fatty liver disease? Hepat Mon. 2013;13:e15227.CrossRefGoogle Scholar
  11. 11.
    Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39:1647–54.CrossRefGoogle Scholar
  12. 12.
    Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast T, Poustchi H. Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease. Int J Food Sci Nutr. 2016;67:1024–9.CrossRefGoogle Scholar
  13. 13.
    Yari Z, Rahimlou M, Eslamparast T, Ebrahimi-Daryani N, Poustchi H, Hekmatdoost A. Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study. Int J Food Sci Nutr. 2016;67:461–9.CrossRefGoogle Scholar
  14. 14.
    Emamat H, Foroughi F, Eini-Zinab H, Taghizadeh M, Rismanchi M, Hekmatdoost A. The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. J Diabetes Metab Disord. 2016;15:25.Google Scholar
  15. 15.
    Eslamparast T, Poustchi H, Zamani F, Sharafkhah M, Malekzadeh R, Hekmatdoost A. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 2014;99:535–42.CrossRefGoogle Scholar
  16. 16.
    Rahimlou M, Yari Z, Hekmatdoost A, Alavian SM, Keshavarz SA. Ginger supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Hepat Mon. 2016;16:e34897.CrossRefGoogle Scholar
  17. 17.
    Trinidad TP, Mallillin AC, Loyola AS, Sagum RS, Encabo RR. The potential health benefits of legumes as a good source of dietary fibre. Br J Nutr. 2010;103:569–74.CrossRefGoogle Scholar
  18. 18.
    Bazzano L, He J, Ogden L, et al. Legume consumption and risk of coronary heart disease in US men and women. NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:2573–8.CrossRefGoogle Scholar
  19. 19.
    Papanikolaou Y, Fulgoni VL 3rd. Bean consumption is associated with greater nutrient intake, reduced systolic blood pressure, lower body weight, and a smaller waist circumference in adults: results from the National Health and Nutrition Examination Survey 1999-2002. J Am Coll Nutr. 2008;27:569–76.Google Scholar
  20. 20.
    Bazzano LA, Thompson AM, Tees MT, Nguyen CH, Winham DM. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2011;21:94–103.CrossRefGoogle Scholar
  21. 21.
    Mokhtari Z, Poustchi H, Eslamparast T, Hekmatdoost A. Egg consumption and risk of non-alcoholic fatty liver disease. World J Hepatol. 2017;9:503–9.CrossRefGoogle Scholar
  22. 22.
    Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13:654–62.CrossRefGoogle Scholar
  23. 23.
    Food and Nutrition Information Center, US Department of Agriculture: Food composition table (FCT). Beltsville, MD. 2009. Accessed 27 June 2011.
  24. 24.
    Azizi F. Legume intake is inversely associated with metabolic syndrome in adults. Arch Iran Med. 2012;15:538–44.Google Scholar
  25. 25.
    Becerra-Tomás N, Díaz-López A, Rosique-Esteban N, et al. Legume consumption is inversely associated with type 2 diabetes incidence in adults: a prospective assessment from the PREDIMED study. Clin Nutr. 2017;37:906–13.CrossRefGoogle Scholar
  26. 26.
    Kang R, Kim M, Chae JS, Lee S-H, Lee JH. Consumption of whole grains and legumes modulates the genetic effect of the APOA5-1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Trials. 2014;15:100.Google Scholar
  27. 27.
    Kim S, Hong J, Jeon R, Kim H-S. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease. Nutr Res. 2016;36:90–100.CrossRefGoogle Scholar
  28. 28.
    Ferolla SM, Ferrari TC, Lima ML, et al. Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. Clinics (Sao Paulo). 2013;68:11–7.Google Scholar
  29. 29.
    Guillon F, Champ M-J. Carbohydrate fractions of legumes: uses in human nutrition and potential for health. Br J Nutr. 2002;88:293–306.CrossRefGoogle Scholar
  30. 30.
    Duranti M. Grain legume proteins and nutraceutical properties. Fitoterapia. 2006;77:67–82.CrossRefGoogle Scholar
  31. 31.
    Thorne MJ, Thompson L, Jenkins D. Factors affecting starch digestibility and the glycemic response with special reference to legumes. Am J Clin Nutr. 1983;38:481–8.CrossRefGoogle Scholar
  32. 32.
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.CrossRefGoogle Scholar
  33. 33.
    Lejeune MP, Westerterp KR, Adam TC, Luscombe-Marsh ND, Westerterp-Plantenga MS. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr. 2006;83:89–94.CrossRefGoogle Scholar
  34. 34.
    Holt SH, Miller JB. Increased insulin responses to ingested foods are associated with lessened satiety. Appetite. 1995;24:43–54.CrossRefGoogle Scholar
  35. 35.
    Anderson GH, Woodend D. Effect of glycemic carbohydrates on short-term satiety and food intake. Nutr Rev. 2003;61 Suppl-5:S17–26.Google Scholar
  36. 36.
    Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13:9.Google Scholar
  37. 37.
    Rebello C, Greenway F, Finley JW. A review of the nutritional value of legumes and their effects on obesity and its related co-morbidities. Obes Rev. 2014;15:392–407.CrossRefGoogle Scholar
  38. 38.
    Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.CrossRefGoogle Scholar
  39. 39.
    Chatterjee R, Yeh H-C, Edelman D, Brancati F. Potassium and risk of type 2 diabetes. Expert Rev Endocrinol Metab. 2011;6:665–72.CrossRefGoogle Scholar
  40. 40.
    Dong J-Y, Xun P, He K, Qin L-Q. Magnesium intake and risk of type 2 diabetes. Diabetes Care. 2011;34:2116–22.CrossRefGoogle Scholar
  41. 41.
    Villegas R, Gao Y-T, Yang G, et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women’s Health Study. Am J Clin Nutr. 2008;87:162–7.Google Scholar
  42. 42.
    Sievenpiper JL, Kendall CW, Esfahani A, et al. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. 2009;52:1479–95.Google Scholar
  43. 43.
    Zhang Z, Lanza E, Kris-Etherton PM, et al. A high legume low glycemic index diet improves serum lipid profiles in men. Lipids. 2010;45:765–75.Google Scholar
  44. 44.
    Birketvedt GS, Travis A, Langbakk B, Florholmen JR. Dietary supplementation with bean extract improves lipid profile in overweight and obese subjects. Nutrition. 2002;18:729–33.CrossRefGoogle Scholar
  45. 45.
    Macarulla MT, Medina C, De Diego MA, et al. Effects of the whole seed and a protein isolate of faba bean (Vicia faba) on the cholesterol metabolism of hypercholesterolaemic rats. Br J Nutr. 2001;85:607–14.CrossRefGoogle Scholar
  46. 46.
    Finley JW, Burrell JB, Reeves PG. Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans. J Nutr. 2007;137:2391–8.CrossRefGoogle Scholar
  47. 47.
    Willett W. Nutritional Epidemiology. New York: Oxford University Press; 2012.CrossRefGoogle Scholar

Copyright information

© Indian Society of Gastroenterology 2019

Authors and Affiliations

  • Alireza Bahrami
    • 1
  • Farshad Teymoori
    • 1
  • Tannaz Eslamparast
    • 2
  • Golbon Sohrab
    • 2
  • Ehsan Hejazi
    • 2
  • Hossein Poustchi
    • 3
  • Azita Hekmatdoost
    • 2
    Email author
  1. 1.Student Research Committee, Department and Faculty of Nutrition Sciences and Food TechnologyShahid Beheshti University of Medical SciencesTehranIran
  2. 2.Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology, Research InstituteShahid Beheshti University of Medical SciencesTehranIran
  3. 3.Liver and Pancreatobiliary Research GroupDigestive Disease Research InstituteTehranIran

Personalised recommendations